Profound Medical (PROF) EPS (Weighted Average and Diluted) (2024 - 2026)

Profound Medical's EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at $0.19 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 47.22% year-over-year to $0.19; the TTM figure through Mar 2026 stood at $1.24 (up 3.33% YoY), while the FY2025 annual figure was $1.41, up 25.89% from the prior year.
• EPS (Weighted Average and Diluted) was $0.19 for Q1 2026 at Profound Medical, down from $0.27 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.52 in Q2 2025 to a low of $0.18 in Q4 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.3 across 3 years, with a median of $0.27 in 2024.
• The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) soared 85.71% in 2025, then slumped 47.22% in 2026.
• A 3-year view of EPS (Weighted Average and Diluted) shows it stood at $0.18 in 2024, then surged by 50.0% to $0.27 in 2025, then declined by 29.63% to $0.19 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.19 (Q1 2026), $0.27 (Q4 2025), and $0.26 (Q3 2025), per Business Quant data.